June 14, 2026 · 13 min read
No stock is truly recession-proof — but certain businesses have demonstrated decade after decade that they hold up when the economy contracts and markets fall. With the NY Fed placing ~30% odds on a US recession over the next 12 months and yield curve signals flashing caution, 2026 is a year to understand the defensive playbook. Here is the complete guide to recession-resistant stocks, sectors, and allocation strategies.
Recession-resistant stocks share five structural traits that allow them to generate earnings and dividends even when the broader economy contracts. These are not coincidences — they are the result of deliberate business model choices that create durability.
Defensive investing is not one-size-fits-all. Each sector offers a different risk/return profile, dividend yield, and economic sensitivity. Understanding how each sector behaves in a downturn helps you build a portfolio that matches your risk tolerance.
Consumer staples is the textbook defensive sector — and for good reason. The -15% drawdown in 2008 and -10% in 2020 versus -37% and -34% for the S&P 500 illustrates why these companies belong in every recession-aware portfolio.
$84B in annual revenue. ~8% operating margin on a business that includes Tide, Pampers, Gillette, Oral-B, and 70+ other category-leading brands. P&G has raised its dividend for 68 consecutive years — through recessions, wars, oil shocks, pandemics, and now AI disruption. The company's organic sales growth consistently exceeds GDP because it operates in categories where volume is relatively stable and it can take price. In recessions, private-label competition does tick up, but P&G's brand loyalty limits share loss. Dividend yield: ~2.4%.
~60% gross margin — one of the highest in consumer goods — reflects Coca-Cola's extraordinary pricing power. People in 200 countries drink Coke regardless of economic conditions, and the company has demonstrated repeatedly that it can raise prices without losing meaningful volume. The 62-year dividend streak includes the Great Recession and COVID. Coca-Cola has also diversified beyond carbonated beverages into water (Smartwater), coffee (Costa), juices, and energy drinks (Monster stake), reducing its reliance on any single category. Dividend yield: ~3.1%.
Walmart is unique among consumer staples: recessions are actually good for it. When consumers tighten budgets, they trade down from Whole Foods, Target, and specialty retailers to Walmart's everyday low prices. Private-label brand penetration increases in downturns, boosting Walmart's margins. In the 2008 GFC, Walmart's stock actually increased ~19% as the S&P fell -37% — one of the great demonstrations of recession-counter-cyclicality. The company's $670B revenue base, grocery dominance, advertising business, and growing Sam's Club membership (50M+ members) provide multiple levers. Market cap: ~$750B. 1-year return: +72%.
Costco's membership fee model creates a floor of predictable revenue that is largely recession-proof — members rarely cancel, especially when bulk savings become more valuable in hard times. Renewal rates above 90% globally. In recessions, Costco actually benefits from trade-down: consumers who used to buy at specialty retailers discover that Costco's Kirkland Signature private label matches or exceeds brand quality at lower cost. The membership model also aligns Costco's incentives with the consumer — low product margins, high membership income — in a way that builds extraordinary loyalty. Dividend yield: ~0.7% (plus special dividends).
| Ticker | Revenue | Div Yield | 5-Yr Return | 2008 GFC | 2020 COVID | Key Moat |
|---|---|---|---|---|---|---|
| PG | $84B | ~2.4% | +62% | -10% | -8% | 68 yr div streak |
| KO | $46B | ~3.1% | +48% | -26% | -13% | 62 yr div streak |
| WMT | $670B | ~1.0% | +180% | +19% | +2% | Trade-down + grocery |
| COST | $242B | ~0.7% | +195% | -10% | +6% | Membership moat |
Healthcare is arguably the most recession-proof major sector. People do not defer cancer treatments, insulin, or hip replacements because the economy is weak. GDP has near-zero impact on healthcare volumes, making the sector a reliable defensive anchor alongside consumer staples.
After spinning off its consumer health division as Kenvue (KVUE), J&J is now a pure-play pharmaceutical and MedTech company — both highly recession-resistant businesses. The pharmaceutical segment generates blockbuster revenues from Darzalex (multiple myeloma), Stelara (immunology), and an expanding oncology pipeline. The MedTech segment — orthopedic implants, surgical tools, cardiovascular devices — is driven by aging demographics and has essentially zero GDP correlation. J&J has increased its dividend for 62 consecutive years, making it one of only a handful of 'Kings' in the Dividend King category. Yield: ~3.4%.
Healthcare insurance is largely non-discretionary, especially employer-sponsored coverage that does not get cancelled when the economy slows. UnitedHealth's managed care business serves 50M+ Americans and benefits from secular growth in Medicare Advantage as Baby Boomers age into government programs. The Optum health services platform — pharmacy benefits, analytics, care delivery — adds high-margin services revenue that compounds alongside insurance growth. In prior recessions, UNH's earnings growth barely blinked. The regulatory risk around drug pricing and PBM reform is the main bear case but has been overhanging the sector for years without materializing fully.
Abbott's diversified medical device and diagnostics business spans continuous glucose monitors (Libre — 6M+ users globally), vascular devices, rapid testing, and nutrition. The recurring revenue nature of CGM sensors — diabetics must replace sensors every 14 days — creates predictable high-margin revenue streams that are recession-insensitive. The Libre platform commands 40%+ global CGM market share and is growing revenue ~20% annually despite the mature market position. Abbott also benefits from hospital capital equipment upgrades that accelerate as hospital finances recover. 52 consecutive years of dividend increases.
Utilities are regulated monopolies — customers literally cannot stop paying their electric bills. This creates predictable, government-guaranteed earnings streams that make utilities one of the safest sectors in a recession. The trade-off: utilities are rate-sensitive. When interest rates rise sharply (as they did in 2022), utilities' high dividend yields look less attractive versus risk-free bonds, causing underperformance. When rates fall in a recession — the Fed's typical response — utilities outperform significantly.
NextEra is the world's largest producer of wind and solar energy while also operating Florida Power & Light, a regulated utility serving 5.8M Florida accounts. The regulated utility business provides recession-proof earnings; the renewable development platform provides growth that most traditional utilities lack. NextEra has raised its dividend every year for 28+ consecutive years. The combination of defensive regulated income and secular growth from the energy transition makes NEE a core defensive holding with above-average total return potential. With rates expected to decline in a recession, NEE's 3%+ dividend yield becomes more attractive.
Duke Energy is one of the largest electric utilities in the US, serving 8.2M customers across the Carolinas, Florida, Indiana, Ohio, and Kentucky. Its rate base of $90B+ grows at ~6% annually through infrastructure investments that regulators approve in advance — a nearly risk-free path to earnings growth. Duke's 3.8% dividend yield is well above the S&P 500 average and has been paid and grown for decades. In an economic downturn, Duke's defensive earnings floor makes it a compelling hold-through vehicle even if the market overall sells off.
AEP serves 5.6M customers across 11 states with a heavy presence in Texas and Ohio. The company is investing aggressively in transmission infrastructure — the backbone of the US grid that moves power from renewable generation to load centers. Transmission projects generate regulated returns that are effectively guaranteed regardless of economic conditions. AEP's 4%+ dividend yield makes it one of the higher-yielding utility options for income-focused defensive investors.
Key utility dynamic: utilities dramatically underperform in bull markets when investors prefer higher-growth sectors, and significantly outperform in downturns and rate-cut cycles when their stable earnings and income become most valuable. They are not long-term outperformers — they are portfolio stabilizers.
Defense stocks occupy a unique position in the defensive universe: they are counter-cyclical not because their products are consumer staples, but because their customer — the US government — spends more on defense during periods of global instability, precisely when the economy is often under stress. NATO members are under pressure to hit 2% GDP defense spending targets, driving European order growth on top of the structural Ukraine/Middle East demand tailwind.
Lockheed's $165B order backlog is the largest in the defense industry and provides exceptional revenue visibility 3–5 years forward. F-35 production (3,000+ jets globally on order), missile defense systems (THAAD, PAC-3), and classified programs generate predictable cost-plus and fixed-price contracts that barely flinch during recessions. NATO allies are actively ordering F-35s as they hit spending targets. Lockheed has raised its dividend for 21+ consecutive years with a yield of ~2.8%. The 2022 bear market saw LMT gain +40% as the S&P fell -25% — the clearest illustration of its counter-cyclical nature.
RTX uniquely combines defense (Raytheon missiles, missile defense, classified programs) with commercial aerospace (Pratt & Whitney engines, Collins Aerospace systems). The defense half is recession-proof; the commercial aerospace half is economic-sensitive but is currently in a multi-year upcycle as global air travel exceeds pre-COVID levels and airlines need engines for new narrowbody orders. Patriot missile systems are in extraordinary demand globally following Ukraine. RTX's balanced exposure makes it a defensive-growth hybrid.
Northrop is the primary contractor for the B-21 Raider stealth bomber — a multi-decade program that will define the future of US strategic airpower. Space systems (satellites, missile early warning) and cyber/intelligence programs add revenue streams tied to classified national security priorities that are essentially recession-proof. Northrop's $50B+ backlog and low-cyclicality business mix make it a reliable defensive hold. The stock tends to re-rate higher when geopolitical risk spikes — exactly the macro environment associated with recession risk.
Insurance companies occupy an overlooked corner of the defensive universe. Their business model — collecting premiums upfront and investing the float before claims are paid — creates a compounding engine that works across economic cycles. The best insurers are also inflation beneficiaries: they can raise premiums faster than claims costs in high-inflation environments.
Berkshire is the ultimate defensive holding — not despite paying no dividend, but in part because of it. Buffett's float-investing model uses ~$160B in insurance float to generate investment income that compounds at exceptional rates. The $160B+ cash position ($340B equity portfolio, $160B+ cash) means Berkshire is uniquely positioned to deploy capital during recessions when assets go on sale, effectively turning downturns into buying opportunities. BRK.B's market cap: ~$980B. YTD return: +15%. Berkshire's businesses — insurance (GEICO), energy (BHE), railroads (BNSF), manufacturing — are diversified across defensive and quasi-cyclical sectors.
Progressive is the #2 auto insurer in the US and one of the fastest-growing financial companies of the last decade. Auto insurance is legally mandatory in 49 states — demand is essentially non-discretionary. Progressive's telematics-based pricing (Snapshot program) gives it an underwriting data advantage that drives above-industry margins. Insurance pricing has remained elevated following the 2021-2023 auto claims inflation surge, and Progressive has successfully passed through premium increases. A classic recession-resistant business with strong organic growth.
Chubb is the world's largest publicly traded property and casualty insurer, with $50B+ in net premiums written. Its high-net-worth personal lines and commercial P&C businesses tend to be stickier than standard lines — wealthy clients don't cancel insurance during recessions. Chubb's disciplined underwriting culture — it has maintained profitable underwriting ratios through multiple catastrophe years — provides confidence in earnings durability. The company has raised its dividend for 31 consecutive years. Yield: ~1.5%, but consistent buybacks add shareholder return.
The S&P 500 Dividend Aristocrats are companies that have increased their dividend every year for at least 25 consecutive years. This is an extraordinarily high bar — it requires surviving the 2001 dot-com recession, the 2008 financial crisis, the 2020 COVID shock, and the 2022 rate spike while still growing shareholder income. The Aristocrats are, by definition, the most battle-tested businesses in the public markets.
| Ticker | Consecutive Years | Current Yield | Sector |
|---|---|---|---|
| JNJ | 62 years | ~3.4% | Healthcare |
| PG | 68 years | ~2.4% | Consumer Staples |
| KO | 62 years | ~3.1% | Consumer Staples |
| MMM | 46 years | ~3.8% | Industrials (post-split) |
| AFL | 42 years | ~2.1% | Insurance |
| ATO | 39 years | ~2.9% | Utilities |
P&G's 68-year streak is the longest in the S&P 500. It means the company raised its dividend through every significant economic event since 1956 — the Cold War, stagflation of the 1970s, Black Monday in 1987, the dot-com crash, the 2008 financial crisis, and COVID. That consistency is the result of a business model that genuinely does not depend on economic cycles to generate cash flow.
Equally important to knowing what to buy is knowing what to avoid. These categories have historically amplified losses in economic downturns.
The numbers tell the story clearly. In every major market downturn since 2000, defensive sectors have dramatically outperformed the broader market on a drawdown basis — the primary goal in a recession is not to win, it is to lose significantly less.
| Period | S&P 500 | Consumer Staples | Healthcare | Utilities | Defense |
|---|---|---|---|---|---|
| 2008 Global Financial Crisis | -37% | -15% | -22% | -29% | -18% |
| 2020 COVID Crash (Feb–Mar) | -34% | -10% | -12% | -20% | -22% |
| 2022 Rate Shock Bear Market | -25% | -3% | -2% | -7% | +8% |
Note: 2022 data shows defense as a clear outlier — the Russia-Ukraine conflict and NATO spending surge made defense stocks counter-cyclical even as both stocks and bonds sold off simultaneously in the rate-shock bear market.
Defensive positioning is not binary — you do not need to go all-in on staples and utilities. The right allocation depends on your investment horizon, income needs, and risk tolerance. Here are three frameworks:
Regardless of allocation, consider maintaining a 10–15% cash position in a recession-risk environment. Recessions create the best buying opportunities in growth stocks — having dry powder to deploy at lower prices is part of the defensive strategy.
With the NY Fed's recession probability model at ~30% over 12 months, the yield curve flattening again, and consumer confidence softening, building a defensive allocation in 2026 is prudent risk management — not pessimism. The best recession-proof stocks are not esoteric: they are the businesses people have been buying for 50+ years whose dividend checks have kept arriving through every crisis.
Our core defensive picks for 2026: PG (68-year dividend King, $84B revenue fortress), WMT (recession beneficiary with +72% 1-year return proving market recognition), JNJ (pure-play pharma/MedTech with 62-year streak), NEE (defensive utility with renewable growth), LMT (counter-cyclical $165B backlog), and BRK.B (the ultimate recession-opportunistic compounder with $160B+ in deployment capital).
Build your defensive position before the recession is obvious — by then, defensive stocks will already have re-rated, and you will be paying full price for the protection. The best time to own an umbrella is before the storm.
Use our analysis tools to compare specific defensive stocks side by side on dividends, valuation, and recession performance.